Impact of Targeted Therapy on Outcome of Chronic Lymphocytic Leukemia Patients with Relapsed Del(17p13.1) Karyotype at a Single Center

Podobne zapisy

• Externally validated predictive clinical model for untreated del(17p13.1) chronic lymphocytic leukemia patients
  od: Stephens, Deborah M., i wsp.
  Wydane: (2015)
• Complex karyotype predicts for inferior outcomes following reduced-intensity conditioning allogeneic transplant for chronic lymphocytic leukaemia
  od: Jaglowski, Samantha M., i wsp.
  Wydane: (2012)
• Outcome of Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) Treated with Flavopiridol: Impact of Genetic Features
  od: Woyach, Jennifer A., i wsp.
  Wydane: (2012)
• Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemia
  od: Heerema, Nyla A., i wsp.
  Wydane: (2020)
• Etiology of Ibrutinib Discontinuation and Outcomes in Chronic Lymphocytic Leukemia Patients
  od: Maddocks, Kami J., i wsp.
  Wydane: (2015)